Amlodipine and Glucotrol xl drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Amlodipine (amlodipine besylate) and Glucotrol xl (glipizide). Common drug interactions include hepatitis a antibody positive among females and fatigue among males.

The phase IV clinical study analyzes what interactions people have when they take Amlodipine and Glucotrol xl. It is created by eHealthMe based on reports of 77 people who take the same drugs from the FDA, and is updated regularly.

What is Amlodipine?

Amlodipine has active ingredients of amlodipine besylate. It is often used in high blood pressure. eHealthMe is studying from 354,829 Amlodipine users. Check the latest studies of Amlodipine.

What is Glucotrol xl?

Glucotrol xl has active ingredients of glipizide. It is often used in diabetes. eHealthMe is studying from 6,863 Glucotrol xl users. Check the latest studies of Glucotrol xl.



On Jul, 20, 2026

77 people who take Amlodipine and Glucotrol xl together, and have interactions are studied.

Amlodipine and Glucotrol xl drug interactions.

What are the common drug interactions of Amlodipine and Glucotrol Xl, by gender? *:

female:

  1. Hepatitis a antibody positive
  2. Leg ulcer (exc varicose) (leg ulcer without varicose vein)
  3. Pyrexia (fever)
  4. Renal failure (kidney dysfunction)
  5. Weakness
  6. Respiratory failure (inadequate gas exchange by the respiratory system)
  7. Blood culture positive
  8. Blood urea increased
  9. Constipation
  10. Drug ineffective

male:

  1. Fatigue (feeling of tiredness)
  2. Malaise (a feeling of general discomfort or uneasiness)
  3. Headache (pain in head)
  4. Hyperhidrosis (abnormally increased sweating)
  5. Localised infection (infection at the single location)
  6. Nausea (feeling of having an urge to vomit)
  7. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  8. Arthralgia (joint pain)
  9. Back disorder
  10. Back pain

What are the common drug interactions of Amlodipine and Glucotrol Xl, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Chronic kidney disease
  4. Depression
  5. Emotional distress
  6. Pain
  7. Renal failure (kidney dysfunction)
  8. Diabetes mellitus inadequate control
  9. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  10. Fatigue (feeling of tiredness)

50-59:

  1. Bipolar disorder (mood disorder)
  2. Depression
  3. Diarrhoea
  4. Dyspnoea (difficult or laboured respiration)
  5. Fatigue (feeling of tiredness)
  6. Feeling hot
  7. Flushing (the warm, red condition of human skin)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Laryngospasm (an uncontrolled/involuntary muscular contraction of larynx)
  10. Ocular vascular disorder (disease of eye blood circulation)

60+:

  1. Malaise (a feeling of general discomfort or uneasiness)
  2. Oedema lower limb (fluid collection in tissue of lower leg)
  3. Drug ineffective
  4. Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
  5. Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
  6. Hepatic failure (liver failure)
  7. Appetite decreased (decreased appetite occurs when you have a reduced desire to eat)
  8. Dyspnoea (difficult or laboured respiration)
  9. Fatigue (feeling of tiredness)
  10. Fluid retention (an abnormal accumulation of fluid in the blood)

What are the existing conditions these people have? *

  1. Pain: 11 people, 14.29%
  2. High Blood Cholesterol: 8 people, 10.39%
  3. Nausea (feeling of having an urge to vomit): 6 people, 7.79%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 7.79%
  5. Type 2 Diabetes: 5 people, 6.49%
  6. Toxic Neuropathy (nerve damage caused by toxic (harmful) substances): 5 people, 6.49%
  7. Neuropathy Peripheral (surface nerve damage): 5 people, 6.49%
  8. Insomnia (sleeplessness): 5 people, 6.49%
  9. Inflammation: 5 people, 6.49%
  10. Hypersensitivity: 5 people, 6.49%

* Approximation only. Some reports may have incomplete information.

Do you take Amlodipine and Glucotrol xl?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Amlodipine and Glucotrol xl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Amlodipine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Glucotrol xl:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Amlodipine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Glucotrol xl and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on amlodipine besylate and glipizide (the active ingredients of Amlodipine and Glucotrol xl, respectively), and Amlodipine and Glucotrol xl (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: